Boston Scientific Corp (BSX.N)

BSX.N on New York Stock Exchange

13.18USD
30 Oct 2014
Price Change (% chg)

-- (--)
Prev Close
$13.18
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
2,657,808
52-wk High
$14.07
52-wk Low
$11.11

BSX.N

Chart for BSX.N

About

Boston Scientific Corporation is a developer, manufacturer and marketer of medical devices that are used in a range of interventional medical specialties. During the year ended December 31, 2011, its products were offered for sale by seven core businesses: Interventional Cardiology, CRM, Endoscopy, Peripheral Interventions,... (more)

Overall

Beta: 1.04
Market Cap (Mil.): $17,472.83
Shares Outstanding (Mil.): 1,325.71
Dividend: --
Yield (%): --

Financials

Search Stocks

UPDATE 1-Boston Scientific 3rd-qtr profit up on heart device sales

Oct 22 - Boston Scientific Corp on Wednesday posted third-quarter profit in line with analysts' expectations on increased sales of its implantable heart devices, and raised its full-year outlook for revenue and profit, excluding items.

22 Oct 2014

Boston Scientific profit up on heart device sales

Oct 22 - Boston Scientific Corp on Wednesday posted a third-quarter profit in line with analysts' expectations on stronger sales of its key implantable heart devices.

22 Oct 2014

FDA panel offers mixed view on Boston Scientific Watchman device

WASHINGTON - An advisory panel to the U.S. Food and Drug Administration offered a mixed view of Boston Scientific Corp's Watchman heart device on Wednesday, concluding it is probably safe but not particularly effective in reducing the risk of stroke in patients with a certain type of irregular heart beat.

09 Oct 2014

FDA panel offers mixed view on Boston Scientific Watchman device

WASHINGTON, Oct 8 - An advisory panel to the U.S. Food and Drug Administration offered a mixed view of Boston Scientific Corp's Watchman heart device on Wednesday, concluding it is probably safe but not particularly effective in reducing the risk of stroke in patients with a certain type of irregular heart beat.

09 Oct 2014

Damages slashed to $34.6 mln in Boston Scientific mesh trial

Oct 3 - A jury award of $73.4 million to a woman who said she was injured by a Boston Scientific Corp transvaginal mesh device has been cut to $34.6 million, thanks to a Texas law that caps how much companies must pay in punitive damages.

03 Oct 2014

Court orders Boston Scientific to pay $308 mln in damages to Mirowski

Sept 24 - Boston Scientific Corp said a U.S. court ruled that it breached its license agreement with Mirowski Family Ventures LLC and awarded Mirowski $308 million in damages.

25 Sep 2014

Freshfields recruits veteran M&A partner from Shearman & Sterling

(This Sept. 15 story changes the 10th paragraph to reflect that Presser was not practicing law at Paine & Partners)

16 Sep 2014

Boston Scientific ordered to pay $73 million over mesh device

Sept 9 - A Texas jury has ordered Boston Scientific Corp to pay $73 million to a woman who said she suffered serious injuries from a transvaginal mesh device, the first loss for the device maker in one of thousands of suits over the products.

10 Sep 2014

Cyberonics device improves heart function after Boston flop

BARCELONA - A nerve stimulation device from Cyberonics improved cardiac function in heart failure patients in a small clinical trial, in contrast to an unsuccessful study backed by Boston Scientific.

01 Sep 2014

Cyberonics device improves heart function after Boston flop

BARCELONA, Sept 1 - A nerve stimulation device from Cyberonics improved cardiac function in heart failure patients in a small clinical trial, in contrast to an unsuccessful study backed by Boston Scientific.

01 Sep 2014

Competitors

Earnings vs. Estimates

Search Stocks